For Immediate Release 10 April 2008
PROTEOME SCIENCES plc
("Proteome Sciences" or the "Company")
PRESS RELEASE
DIRECTORS' SHAREHOLDINGS
Proteome Sciences announces that on 10 April 2008 it granted a conditional award
of 306,667 ordinary shares of 1p each in the Company ("Ordinary Shares") to
Dr P.Schulze-Knappe, Research and Development Director, under its Long-Term Incentive Plan ("LTIP")
based on a closing mid-market price on 9 April 2008 of 37.5p per Ordinary Share.
In accordance with the rules of the LTIP, the Ordinary Shares awarded will vest
three years after the date of grant subject to the Company achieving a target
total shareholder return (TSR) over a three-year performance period relative to
a comparator group of companies at the start of that period. TSR is the
aggregate of share price growth and the value of dividend payments during the
performance period. No shares will be released unless the Company's TSR
performance is in the median position of the comparator group with full vesting
only if the Company is in the upper quartile. 30% of the award will vest if
performance is at the median, and where performance is between the 50th and
75th percentiles awards will vest on a straight line basis.
The Remuneration Committee of the Board of Directors believes that today's
award under the LTIP aligns the interests of shareholders with those of the
executive by making the award dependent on the success of management in
delivering superior returns to shareholders.
Dr Schulze-Knappe currently holds no shares in the Company, but has a previous
conditional award under the LTIP of up to 319,444 shares.
Proteome Sciences plc
Christopher Pearce
Chief Executive Officer
christopher.pearce@proteomics.com
James Malthouse
Finance Director
james.malthouse@proteomics.com
Tel: +44 (0)1932 865065
Nominated Adviser
Landsbanki Securities (UK) Limited
Gareth Price / Thilo Hoffman
Tel: +44 (0)20 7426 9000
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.